Home › Kanser sa Prostate › Michigan › Ann Arbor
Pag-aaral pangklinika para sa Kanser sa Prostate sa Ann Arbor, MI
Isang pag-aaral para sa Kanser sa Prostate ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Ann Arbor. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Nagre-recruitPhase 3
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi ang layo
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi ang layo
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi ang layo
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Nagre-recruitPhase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Nagre-recruitPhase 2
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi ang layo
- Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · 15 mi ang layo
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi ang layo
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi ang layo
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi ang layo
- at 4 pa
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Nagre-recruitPhase 2
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi ang layo
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi ang layo
- at 4 pa
Precision-Based Genomics in Prostate Cancer
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan, Ann Arbor
Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 1/2
- Research Site, Ann Arbor
Carboplatin or Olaparib for BRcA Deficient Prostate Cancer
Nagre-recruitPhase 2
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
A Clinical Study of Ifinatamab Deruxtecan (I-DXd) in People With Metastatic Prostate Cancer (MK-2400-001)
Nagre-recruitPhase 3
- University of Michigan ( Site 0005), Ann Arbor
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Nagre-recruitPhase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- Chelsea Hospital, Chelsea · 15 mi ang layo
- at 2 pa
Prostate Active Surveillance Study
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan, Ann Arbor
COMPASS Study for Metastatic Castration-resistant Prostate Cancer
Nagre-recruitObservasyonal na pag-aaral
- Rogel Cancer Center, Ann Arbor
EDRN Prostate MRI Biomarker Study
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan, Ann Arbor
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
Nagre-recruitPhase 2
- University of Michigan Health, Ann Arbor
SPECT/CT Imaging for Dosimetry in 177Lu-PSMA-617 (Pluvicto) Therapy
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Nagre-recruitPhase 3
- Veteran's Administration Medical Center - Ann Arbor, Ann Arbor
- University of Michigan Rogel Cancer Center, Ann Arbor
- University of Michigan - Brighton Center for Specialty Care, Brighton · 18 mi ang layo
Abiraterone, Enzalutamide, or Apalutamide in Castrate-sensitive Prostate Cancer.
Nagre-recruitPhase 2
- VA Ann Arbor Healthcare System, Ann Arbor
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan Rogel Cancer Center, Ann Arbor
Ruxolitinib and Enzalutamide for the Treatment of Metastatic Castration-Resistant Prostate Cancer
Nagre-recruitPhase 1/2
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Veterans Affairs Seamless Phase II/III Randomized Trial of STAndard Systemic theRapy With or Without PET-directed Local Therapy for Oligometastatic pRosTate Cancer
Nagre-recruitPhase 2/3
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Nagre-recruitPhase 3
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
- Huron Gastroenterology PC, Ypsilanti · 7 mi ang layo
- Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · 7 mi ang layo
- at 4 pa
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
Nagre-recruit
- University of Michigan Comprehensive Cancer Center, Ann Arbor
Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])
Nagre-recruitPhase 2
- University of Michigan Rogel Cancer Center, Ann Arbor
Randomized Phase II Trial of Targeted Radiation With no Castration for Mcrpc
Nagre-recruitPhase 2Malugod na tinatanggap ang malusog na boluntaryo
- VA Ann Arbor Healthcare System, Ann Arbor, MI, Ann Arbor
Interstitial Assessment of Architectural Heterogeneity in Prostate Cancer Using a Fine Needle Photoacoustic Probe
Nagre-recruitObservasyonal na pag-aaral
- University of Michigan Rogel Cancer Center, Ann Arbor
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Ann Arbor
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Nagre-recruitPhase 3
- Saint Joseph Mercy Hospital, Ann Arbor
- University of Michigan Comprehensive Cancer Center, Ann Arbor
- Saint Joseph Mercy Chelsea, Chelsea · 15 mi ang layo
- at 1 pa
Pag-aaral para sa Kanser sa Prostate sa ibang lungsod
- New York City, NY103 pag-aaral
- Houston, TX76 pag-aaral
- Los Angeles, CA61 pag-aaral
- Boston, MA59 pag-aaral
- St. Louis, MO46 pag-aaral
- Chicago, IL45 pag-aaral
- San Francisco, CA45 pag-aaral
- Philadelphia, PA44 pag-aaral
- Baltimore, MD43 pag-aaral
- Nashville, TN43 pag-aaral
- Seattle, WA42 pag-aaral
- Washington, DC38 pag-aaral
Iba pang pag-aaral sa Ann Arbor
- Kanser sa Suso27 pag-aaral
- Non-Small Cell Lung Cancer26 pag-aaral
- Kanser (lahat ng uri)25 pag-aaral
- Kanser sa Baga23 pag-aaral
- Colorectal Cancer23 pag-aaral
- Pagkabigo ng Puso22 pag-aaral
- Acute Myeloid Leukemia17 pag-aaral
- Sakit sa Puso at Ugat ng Dugo16 pag-aaral
- Kanser sa Pancreas14 pag-aaral
- Melanoma12 pag-aaral
- Stroke12 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg12 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.